Healthcare Investing in the Post Covid-19 Era: Implications for Value Creation in PE

The COVID-19 crisis has been accelerating change we already knew we needed to make in healthcare. Over the last couple of months we have seen a number of themes play out at unprecedented pace: shift to telemedicine and telehealth, remote clinical trials, shortened lab-to-market timelines for vaccines and drugs. Recent developments are likely to have a lasting impact on healthcare as a sector, and all the supporting infrastructure around it. What will this mean for Private Equity Investors and how are they thinking about value creation given the current disruption in the marketplace?
As part of this webinar we will look to explore what are some of the opportunities that are emerging for PE in healthcare, looking at the different segments where PE plays (e.g. services providers/CROs, pharma/ biotech companies, providers etc. ) and the implications and opportunities for each area.